Search Results 831-840 of 14754 for anti-TNF drugs

  1. Pneumococcal 15-Valent Conjugate Vaccine (Intramuscular Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  2. Nepafenac (Ophthalmic Route) Description and Brand Names - Mayo Clinic

    Nepafenac eye drops is used to treat pain and swelling of the eye following cataract surgery. This medicine is a topical nonsteroidal anti-inflammatory drug ( ...

  3. Emtricitabine And Tenofovir (Oral Route) Description and Brand Names - Mayo Clinic

    Emtricitabine and tenofovir disoproxil fumarate combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is ...

  4. Decongestant And Analgesic Combinations (Oral Route) Before Using - Mayo Clinic

    Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

  5. Glyburide, Micronized (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Drugs used in chemotherapy ... TNF] agents) within 2 weeks prior to cycle 1, day 1: ... A stable regimen of highly active anti-retroviral therapy (HAART); ...

  7. Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

    About this study. This phase II trial studies how well combination chemotherapy and pralatrexate works in treating patients with non-Hodgkin lymphoma (NHL).

  8. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability, drug/body interactions, and preliminary activity of LAM-002A for the treatment of patients ...

  9. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

    Research has shown us that obesity increases likelihood of nonresponse to treatment with tumor necrosis factor α (TNFα) inhibitors, a staple in the treatment of ...

  10. Nilutamide (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...